Axmed, the groundbreaking B2B marketplace revolutionizing access to essential medicines, has been honored as a 2024 Norrsken Impact/100 startup. This esteemed recognition highlights Axmed as one of the most promising impact-driven companies globally, underscoring its commitment to ensuring life-saving medicines reach those in need, regardless of location.
Global Recognition During New York Climate Week
As part of the celebration, Axmed’s logo was prominently displayed on the iconic Nasdaq Tower in Times Square during New York Climate Week 2024. This visibility symbolizes Axmed’s dedication to advancing healthcare equity in underserved regions and its place among a range of global companies providing “100 ways to fix the future.”
A Beacon of Hope in Global Health
Emmanuel Akpakwu, CEO of Axmed, expressed gratitude for the recognition: “Norrsken created the Impact/100 to inspire hope and positive change. We’re honored to be part of this movement and remain committed to transforming healthcare by making critical medicines accessible, especially in low- and middle-income countries.”
Pioneering HealthTech Solutions
As an emerging leader in HealthTech, Axmed joins an elite group of startups addressing pressing global challenges in line with the UN’s sustainable development goals. The Norrsken Impact/100 spotlights these innovative companies, emphasizing their potential for creating lasting, global impact.
Looking Ahead: Expanding Access and Partnerships
Bolstered by this award, Axmed is poised for its next growth phase:
– Enhancing its marketplace platform
– Expanding strategic partnerships
– Ensuring equitable access to essential medicines across communities
About Axmed
Axmed is transforming healthcare access in LMICs through its innovative B2B marketplace. By bridging the gap between healthcare providers and pharmaceutical manufacturers, Axmed is driving more equitable healthcare solutions worldwide.
Contact Information
Axmed
Media Contact: Katie Clift
Phone: +351 913 976 202
Email: katie@maybe.agency
Website: https://www.axmed.com